Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare the effectiveness of reducing intra-cesarean section nausea and vomiting with regional anesthesia in subjects who will receive scopolamine patch with acupressure point P6 stimulation versus subjects that receive just scopolamine patch versus subjects that receive just acupressure point P6 stimulation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rutgers, The State University of New Jersey
• Treatments: Anesthetics; Butylscopolammonium Bromide; Scopolamine; Scopolamine Hydrobromide

Criteria

Inclusion Criteria:

1. Female subjects ages 18 to 45

2. Subjects with ASA Class I or II

3. Subjects with elective primary or repeat cesarean delivery

4. Subjects who receive spinal and/or epidural anesthesia

5. English and non-English speaking subjects will be included in the study

Exclusion Criteria:

1. Female subjects <18 years of age

2. Subjects requiring emergent cesarean delivery

3. Gestational age < 37 weeks

4. History of placenta accreta

5. Multiple gestation pregnancy

6. ASA status III or higher

7. Current history of pregnancy induced hypertension, pre-eclampsia, or eclampsia

8. History of any chronic medication use (other than prenatal vitamins), including inhaler medications

9. Current urinary tract infection, pneumonia, or otitis media

10. Coagulopathies or skin infections overlying the spine

11. History of open angle glaucoma, seizures or psychosis